Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

    NEXT STORY
    ASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica Journal
    PREV STORY
    Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Lexicon Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on August 1, 2019

    author_avatar
    NASDAQ Market News

    Almirall and Athenex announce strategic partnership for the treatment of actinic keratosis

    Almirall and Athenex have entered into a strategic partnership to develop and commercialize KX2-391 ...

    author_avatar
    NASDAQ Market News

    Global Tissue Imaging Market (2020 to 2030) – Focus on Technology, Product, Application, End-user, 14 Countries Data and Competitive Landscape

    author_avatar
    NASDAQ Market News